Beyond a Market Correction, Moves to Make Now Even experienced investors can get shaken by sudden market corrections, before you consider your next move, here are some important things to consider MarketBeat · Mar 12, 2025
3 Dividend Picks Standing Strong as Bond Yields Fall Falling bond yields might create a rotation into these attractive dividend stocks as relative yields become preferential for investors. MarketBeat · Mar 12, 2025
NVIDIA Stock Remains Stunningly Undervalued—Here’s Why NVIDIA is on track to hit new highs this year, but they may not come until the second half, after policy-related fears have died down. MarketBeat · Mar 11, 2025
Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy Oracle's position in the cloud and AI was cemented in F2025, positioning the company to accelerate its growth over the next two years. MarketBeat · Mar 11, 2025
U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave China, emerging markets, and Europe have outperformed the U.S. in 2025, with China’s FXI ETF up 18%, EEM up 4%, and IEV up 13% YTD. MarketBeat · Mar 11, 2025
Joby Aviation: From Prototype to Profitability Joby Aviation's air taxi vision takes flight, solidifying market leadership through certification strength, funding and operational gains. MarketBeat · Mar 11, 2025
Marvell’s 40% Drop Presents a Compelling Buying Opportunity AI-driven chip stock Marvell is down in the dumps to start 2025. Is now the time to get in, or wait for the dust in the market to settle? MarketBeat · Mar 11, 2025
These 3 Dividend Stocks Jumped 15% in a Month—More to Come? Dividend stocks aren't just for long-term income generation. These three shares have jumped 15% in one month while also offering dividend payouts. MarketBeat · Mar 11, 2025
Tesla Stock Is Oversold - Is Now the Time to Be Brave? Tesla is down 55% from its high, but analysts still see 150% upside. In addition, an RSI of 20 suggests extreme oversold conditions. MarketBeat · Mar 11, 2025
3 Stocks Institutions Are Quietly Dumping Institutions have been selling out of discretionary consumer names lately, signaling a loss of confidence in the underlying economy and spending. MarketBeat · Mar 11, 2025
Moderna: 4 Key Reasons the CEO Just Bought $5M in Shares Moderna stock has fallen to levels not seen in 5 years, but the CEO just spent $5 million buying stock in the open market underscoring his optimism for gains. MarketBeat · Mar 11, 2025
Walgreens Boots Alliance: Don’t Write Off This Asset Champ Yet Walgreens Boots Alliance agreed to an $11.45 per share buyout by Sycamore Partners, but shareholders can reject the deal and holdout for a better offer. MarketBeat · Mar 11, 2025
5 ETFs Poised to Spring Ahead in the Second Quarter Here are five thematic ETFs that appear to be ideal for the current market conditions; each fund is delivering strong performance with low fees MarketBeat · Mar 11, 2025
3 Stocks With Sky-High Buyback Yields Over the Last 12 Months Check out these three stocks that have bought back shares big-time over the past 12 months, resulting in buyback yields of 10% or more. MarketBeat · Mar 11, 2025
MarketBeat · Mar 11, 2025 Top 3 Utilities Stocks Powering Up as Recession Fears Rise Three utilities firms may stand out to investors seeking a refuge amid concerns about an impending recession, although each has a different profile.
MarketBeat · Mar 11, 2025 Hidden Gems: 5 Stocks Under $10 With Massive Growth Potential Uncover five promising stocks under $10, each poised for gains across diverse sectors for the second quarter of 2025.
MarketBeat · Mar 11, 2025 Costco Price Plunge Equals Opportunity for Investors Costco continues to take share from its competitors as it leads the industry in growth. Analysts are lifting their stock price targets, leading to new highs.
MarketBeat · Mar 11, 2025 3 Stocks Investing $650 Billion in the U.S.—Should You Invest? See which three large-cap stocks are planning to invest a total of over $650 billion in the United States over the next several years.
MarketBeat · Mar 10, 2025 Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors Novo Nordisk slashed prices on its GLP-1 obesity drugs as it launches NovoCare to gain compounded GLP-1 users as the compounding labs face deadlines to cease.
MarketBeat · Mar 10, 2025 3 Tech Stocks Defying Sector Weakness and Thriving in 2025 Check out these three tech stocks that are all up at least 15% this year. They are defying the disappointing performance of the tech sector so far in 2025.
MarketBeat · Mar 10, 2025 Energy and Basic Materials Sectors Will Dominate in 2025 Put option buyers might have just bet the wrong way about the energy and basic materials sectors, where investors can profit.
MarketBeat · Mar 10, 2025 Silver Pushes Past Gold This Year, These Stocks Will Capitalize Three companies focusing primarily on silver mining may appeal to investors looking to capitalize on the metal's strong performance in 2025.
MarketBeat · Mar 10, 2025 These 3 Q1 Earnings Winners Will Go Higher Despite a lackluster earnings season for many companies, these three firms stood out and exhibited signs of likely future growth as a bonus.
MarketBeat · Mar 10, 2025 Archer Aviation Stock Climbs as Midnight eVTOL Nears Reality Archer Aviation's Midnight aircraft is showing great potential in the eVTOL market, supported by strong financial backing and key strategic partnerships.
MarketBeat · Mar 10, 2025 3 Defensive Investments for a Market Under Pressure Defensive investments like Gold, Consumer Staples, and Dividend ETFs offer stability, steady income, and diversification, helping investors amid uncertainty.